2009 - 2009 Chemotherapy after stenting is feasible for metastatic gastric cancer with pyloric stenosis.
2007 - 2007 Advantages of endoscopic submucosal dissection over conventional endoscopic mucosal resection for neoplasms. Poster presentation
ADAM familyおよびHB-EGF-CTF核内移行を標的とした新規消化器癌分子標的治療法の探索
全件表示
論文 (199件):
Yusuke Okuda, Takaya Shimura, Yuichi Abe, Hiroyasu Iwasaki, Ruriko Nishigaki, Shigeki Fukusada, Naomi Sugimura, Mika Kitagawa, Tamaki Yamada, Ayumu Taguchi, et al. Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer. Journal of gastroenterology. 2024. 59. 9. 883-885
Peng Zhang, Changjuan Tao, Ye Lu, Peijing Li, Xing Wang, Yujie Dai, Yun Xi, Takaya Shimura, Xinfang Li, Jianmin Fang, et al. Epigenetic Reprogramming Potentiates ICAM1 Antibody Drug Conjugates in Preclinical Models of Melanoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2024. 11. 30. e2400203
Makiko Sasaki, Takaya Shimura, Hirotada Nishie, Keita Kuroyanagi, Takuya Kanno, Shigeki Fukusada, Naomi Sugimura, Yusuke Mizuno, Takayuki Nukui, Konomu Uno, et al. BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report. World journal of gastrointestinal oncology. 2024. 16. 7. 3357-3363
Yusuke Okuda, Takaya Shimura, Yuichi Abe, Hiroyasu Iwasaki, Ruriko Nishigaki, Shigeki Fukusada, Naomi Sugimura, Mika Kitagawa, Tamaki Yamada, Ayumu Taguchi, et al. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer. Journal of gastroenterology. 2024
Daigaku Nakamura, Takeshi Yanagita, Yoshiaki Fujii, Kaori Watanabe, Takuya Suzuki, Hajime Ushigome, Ruriko Nishigaki, Naomi Sugimura, Mamoru Tanaka, Ryo Ogawa, et al. Unanticipated pathological clearance in two cases of clinical T4b dMMR/MSI-h advanced colorectal cancer: the potential of immune checkpoint inhibitors despite positive positron-emission tomography results. Surgical case reports. 2024. 10. 1. 105-105
Masato Nakamura, Akihito Tsuji, Yoshihiro Okita, Toshihiko Matsumoto, Tamotsu Sagawa, Takanori Watanabe, Kozo Kataoka, Dai Manaka, Kazuhiro Shiraishi, Naoya Akazawa, et al. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with combination chemotherapy with anti-EGFR antibody: JACCRO CC-16. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 4
The Almost All Colorectal Endoscopic Submucosal Dissection Related Late Local Peritonitis Can Treat Conservatively Without Operation
(GASTROINTESTINAL ENDOSCOPY 2017)
Long-term outcome of transanal colorectal tube for distal stage II/III colorectal cancer with acute colorectal obstruction
(JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2016)
Urinary ADAM12 and MMP-9/NGAL Complex Detect the Presence of Gastric Cancer
(GASTROENTEROLOGY 2015)
C-reactive protein as an independent prognostic factor for metastatic gastric cancer
(JOURNAL OF CLINICAL ONCOLOGY 2013)
2021/07 - 現在 日本消化器病学会 機関紙編集委員 (Journal of Gastroenterology)
2020/10 - 2021/12 Cancers Guest Editor
受賞 (3件):
2014/03 - The Surgical Research Council’s, 10th Annual Symposium in Cellular, Molecular, and Clinical Research in Surgery. The Winner Potential of urinary MMP-9/NGAL complex as a novel non-invasive biomarker for the early detection of gastric cancer
2009/02 - 日本消化管学会 日本消化管学会学会賞最優秀賞(基礎部門) Suppression of proHB-EGF Carboxy-terminal Fragment Nuclear Translocation: A New Molecular Target Therapy for Gastric Cancer